Where does Advanced Bifurcation Systems Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Advanced Bifurcation Systems Inc. ranks #9,955 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Advanced Bifurcation Systems Inc. hold?

Advanced Bifurcation Systems Inc. holds 31 US utility patents granted between 2015 and 2025, spanning 5 technology areas.

What is Advanced Bifurcation Systems Inc.'s Innovation Score?

Advanced Bifurcation Systems Inc. has an Innovation Score of 39.0 out of 100 (top 39% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Advanced Bifurcation Systems Inc.'s patent grant rate increasing or decreasing?

Advanced Bifurcation Systems Inc.'s recent grant velocity is +36% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Advanced Bifurcation Systems Inc.'s patents?

Advanced Bifurcation Systems Inc.'s patents average 16.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Advanced Bifurcation Systems Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Advanced Bifurcation Systems Inc.

Q: What technology areas does Advanced Bifurcation Systems Inc. focus on?

Advanced Bifurcation Systems Inc.'s top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 29 patents, ranking #223 of 3,082 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 31 granted patents across 5 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Advanced ranks #9,955 of 49,997 tracked US assignees by granted-patent volume, with 31 patents across 5 technology areas.

#9,955
of 49,997 US assignees by volume: Top 39%
by Innovation Score (39.0/100): 16.6
avg claims per patent: +36%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9955 · US Corporation #9,955 · 31 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 31 grants
UPPER-Q #9,955/49,997
PHOTO-FINISH Acetylon Pharmaceuti…
CPC-NARROW A61F · 5 areas
INNOV-THIN 39.0/100
CLAIMS-RICH 16.6 claims/avg
TYPE-USCORP US Corporation
VEL-UP +36% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Acetylon Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Advanced’s 39.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.0 pts (31%) Velocity 9.2 pts (24%) Breadth 7.9 pts (20%) Claim depth 10.0 pts (26%)

Qualcomm Incorporated · highest

85
Advanced Bifurcation… · this assignee

39
Deepmap · near

39
Micell · near

39
Moldino Tool… · near

39
Rodan & Fields · near

39
3D Lighting… · lowest

7

What this shows Advanced's Innovation Score is 39.0/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Advanced?

Each dot is one of Advanced’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Advanced’s own 16.6 claims/patent is ABOVE the 14.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Advanced vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Advanced's grants concentrate

Advanced Bifurcation Systems Inc. is a focused PatentsView assignee: 5 CPC subclasses with 93.5% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2022 (5 grants) versus a trough of 1 in 2015. By volume, Advanced sits between Acetylon Pharmaceuticals, Inc. and Amzetta Technologies, LLC.

Advanced's three-year grant acceleration

Advanced Bifurcation Systems Inc. shows 11 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Acetylon Pharmace…

31
Actuant

31
Adams Mfg

31
Adshir

31
Advantest Test So…

31
Allergan Pharmace…

31
Amer Sports Canada

31
Amzetta

31
Advanced Bifurcat… ◀

31

What this shows Advanced holds 31 patents at rank #9,963, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Advanced

By rank, the assignees closest to #9,963 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Advanced's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Advanced, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Advanced ranks #223 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Micell Technologies, Inc. 39 Deepmap Inc. 39 Moldino Tool Engineering, Ltd. 39 Rodan & Fields, LLC 39

Advanced's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Advanced Bifurcation Systems Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	3.2%
2016	2	6.5%
2017	3	9.7%
2018	1	3.2%
2019	4	12.9%
2020	1	3.2%
2021	3	9.7%
2022	5	16.1%
2023	2	6.5%
2024	4	12.9%
2025partial year	5	16.1%

Which technologies does Advanced Bifurcation Systems Inc. patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 29

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 23

A61B - DIAGNOSIS; SURGERY; Identification 5

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 4

Y10T - Technical Subjects Covered BY Former US Classification 4

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Advanced Bifurcation Systems Inc.'s patent record in context - here's where to go next.

Advanced Bifurcation Systems Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 93.5% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #9,955 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Advanced Bifurcation Systems Inc. against Acetylon Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.